India's Panacea Biotec rises on UNICEF vaccine order
** Shares of Panacea Biotec PNCA.NS rise 2% to 409 rupees ** Pharma co receives letter of award from UNICEF for supply of bivalent oral polio vaccine worth 3.15 bln rupees ($35.49 mln) ** More than 645,026 shares change hands, 3.4x of 30-day avg ** Stock down 2.1% YTD ($1 = 88.7600 Indian rupees) (Reporting by Rudra Pratap Singh in Bengaluru) ((rudrapratap.singh@thomsonreuters.com))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility